M&A Advisory for
Pharma and MedTech companies
Over 100 transactions closed
since 1987
Supporting clients
across the globe
Pharma M&A Report 2018
KP publishes the seventh edition of its report M&A activity and major trends in the Pharma industry. As in previous editions, it goes beyond mere... more
An interactive global map of Pharma...
CMOs have been very active in M&A in the last few years, driving consolidation among CMOs, but increasingly also acquiring manufacturing sites from... more
What drives Mergers & Acquisitions in...
The pharmaceutical industry probably sees more M&A activity than any other industry, both in the number of deals and the amount of money spent on... more
Sale of LUZ Inc to RWS Plc
Kurmann Partners has completed the sale of LUZ Inc (www.luz.com) to RWS Group Plc (www.rws.com). The transaction value was US$ 82.5m. LUZ is a... more
Sale of Pro Farma AG to Recordati SpA
Kurmann Partners has concluded the sale of Pro Farma AG (Switzerland) to Recordati SpA (Italy). Pro Farma markets proprietary and in-licensed... more
Sale of extrakt chemie Dr. Bruno...
Kurmann Partners successfully concluded the selling process of Germany based extrakt chemie to Frutarom, one of the world’s 10 largest companies in... more
The European OTC market is undergoing...
The market share of the top 10 OTC firms has increased from just over 30% to nearly 50% in only three years! The European OTC market is going... more
Sale of CAS Clean Air Service AG to...
Kurmann Partners led the selling process for the Switzerland based CAS. CAS is a leading specialist for clean room measuring services and... more
KP advises on the sale of an Alcon...
KP advised Alcon, a Novartis Division, on a strategic collaboration with Swedish CDMO Recipharm AB. The resulting transaction combines a long term... more
KP assists Tillotts Pharma AG in the...
Tillotts Pharma AG, the European affiliate of the Japanese Zeria Pharmaceutical, has acquired the global rights for Entocort® (budesonide) outside the... more
Sale of Novartis' Manufacturing Facility...
Kurmann Partners advised Novartis on the divestment of its Taboa da Serra plant as a going concern to União Quimica, one of the larger national... more
Sale of Hameln Pharma to the Siegfried...
Kurmann Partners led the sale of the sterile filling business of the Hameln Group, "Hameln Pharma" consisting of Hameln Pharma GmbH, Hameln RDS and... more